{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:57:07Z","timestamp":1791986227995,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GlaxoSmithKline foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2018.05.073","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T02:15:19Z","timestamp":1544408119000},"page":"3761-3769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study"],"prefix":"10.1016","volume":"37","author":[{"given":"Lucy","family":"Studholme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trusha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Care","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Karin","family":"Nordgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Vipond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.073_b0005","first-page":"1","article-title":"Current knowledge and future directions of TLR and NOD signaling in sepsis","volume":"2","author":"Foley","year":"2015","journal-title":"Mil Med Res"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.073_b0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.073_b0015","first-page":"201","article-title":"Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed","volume":"10","author":"Dinarello","year":"2004","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2018.05.073_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tiv.2015.12.004","article-title":"Applicability of the monocyte activation test (MAT) for hyperimmune sera in the routine of the quality control laboratory: comparison with the Rabbit Pyrogen Test (RPT)","volume":"32","author":"da Silva","year":"2016","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.073_b0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.20.3.323-329.1984","article-title":"Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli","volume":"20","author":"Dinarello","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.073_b0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jim.2004.03.002","article-title":"Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis","volume":"288","author":"Gaines Das","year":"2004","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.073_b0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2015.07.025","article-title":"Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test","volume":"73","author":"Gimenes","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.073_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/026119290102900203","article-title":"Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European centre for the validation of alternative methods. european centre for the validation of alternative methods","volume":"29","author":"Hartung","year":"2001","journal-title":"Altern Lab Anim"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.073_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14573\/altex.2013.2.169","article-title":"Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test","volume":"30","author":"Hasiwa","year":"2013","journal-title":"Altex"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.073_b0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jim.2005.01.010","article-title":"International validation of novel pyrogen tests based on human monocytoid cells","volume":"298","author":"Hoffmann","year":"2005","journal-title":"J Immunol Methods"},{"issue":"8577","key":"10.1016\/j.vaccine.2018.05.073_b0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(88)90338-8","article-title":"Detection of pyrogen by cytokine release","volume":"1","author":"Poole","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.05.073_b0060","first-page":"121","article-title":"Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes","volume":"69","author":"Poole","year":"1988","journal-title":"Dev Biol Stand"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.073_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-1759(02)00519-7","article-title":"A rapid 'one-plate' in vitro test for pyrogens","volume":"274","author":"Poole","year":"2003","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.073_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-1759(91)90232-5","article-title":"Measurement of cytokine production by the monocytic cell line Mono Mac 6 using novel immunoradiometric assays for interleukin-1 beta and interleukin-6","volume":"144","author":"Rafferty","year":"1991","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2018.05.073_b0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.2042-7158.1991.tb03540.x","article-title":"Assay of pyrogens by interleukin-6 release from monocytic cell lines","volume":"43","author":"Taktak","year":"1991","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.073_b0080","first-page":"73","article-title":"Replacement, reduction and refinement","volume":"19","author":"Flecknell","year":"2002","journal-title":"ALTEX"},{"key":"10.1016\/j.vaccine.2018.05.073_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jim.2014.01.005","article-title":"Cryopreservation of human monocytes for pharmacopeial monocyte activation test","volume":"405","author":"Koryakina","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2018.05.073_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2015.12.001","article-title":"Leukoreduction system chambers provide a valuable source of functional monocytes for the monocyte activation test by comparison with internationally validated methods","volume":"428","author":"Nordgren","year":"2016","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.vaccine.2018.05.073_b0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/1753425915583365","article-title":"An improved monocyte activation test using cryopreserved pooled human mononuclear cells","volume":"21","author":"Solati","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.vaccine.2018.05.073_b0100","unstructured":"European Medicines Agency. Bexsero meningococcal group B vaccine (rDNA, component, adsorbed). 2013. www.ema.europa.eu."},{"issue":"20","key":"10.1016\/j.vaccine.2018.05.073_b0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.15585\/mmwr.mm6520a3","article-title":"Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016","volume":"65","author":"Biswas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.073_b0110","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2014-4015","article-title":"First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak","volume":"135","author":"McNamara","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.073_b0115","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"9869","key":"10.1016\/j.vaccine.2018.05.073_b0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.073_b0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14573\/altex.1509291","article-title":"Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccines","volume":"33","author":"Vipond","year":"2016","journal-title":"ALTEX"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.073_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2009.10.013","article-title":"Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412","volume":"352","author":"Findlay","year":"2010","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.073_b0135","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol J"},{"issue":"8","key":"10.1016\/j.vaccine.2018.05.073_b0140","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4014\/jmb.1604.04080","article-title":"Bacterial outer membrane vesicles as a delivery system for virulence regulation","volume":"26","author":"Yoon","year":"2016","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2018.05.073_b0145","first-page":"73","article-title":"Collaborative study for the establishment of the WHO 3rd International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. Pharmeur Bio Sci","volume":"2015","author":"Findlay","year":"2015","journal-title":"Notes"},{"key":"10.1016\/j.vaccine.2018.05.073_b0150","unstructured":"EDQM - Council of Europe. CombiStats v5.0. 2017. www.combistats.eu."},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.073_b0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.54.4.275","article-title":"Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets","volume":"54","author":"Halvorsen","year":"1993","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.073_b0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CVI.00342-09","article-title":"Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants","volume":"17","author":"Stoddard","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.05.073_b0165","doi-asserted-by":"crossref","unstructured":"Troelstra A, de Graaf-Miltenburg LA, van BT, Verhoef J, Van Kessel KP, Van Strijp JA. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b\/CD18. J Immunol 1999 Apr 1;162(7):4220-4225.","DOI":"10.4049\/jimmunol.162.7.4220"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.073_b0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0968051907080024","article-title":"Potentiation of Toll-like receptor-induced cytokine production by (1\u2013>3)-beta-D-glucans: implications for the monocyte activation test","volume":"13","author":"Kikkert","year":"2007","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2018.05.073_b0175","doi-asserted-by":"crossref","unstructured":"Gianchecchi E, Torelli A, Piccini G, Piccirella S, Montomoli E. N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network. Vaccines (Basel) 2016 May 27;4(2).","DOI":"10.3390\/vaccines4020020"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:46Z","timestamp":1759401166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X18307163"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}